Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-11

Clinical Trial Update: Expression Profiling of microRNA Following Administration of Dexmedetomidine [NA]

View source ↗

Summary

A completed clinical trial evaluated microRNA expression profiling after administration of dexmedetomidine in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: First Affiliated Hospital of Kunming Medical University | Conditions: Coronary Disease | NA | Status: COMPLETED